Tag: dispensaries
-
Why legal cannabis in BC is completely fucked, and literally the worst system in Canada
I had an idea a few weeks ago, one that I hadn’t bothered with sooner because, truth be told, I’m not a weed guy. I like the investment opportunity, and I’ve lately taken to the wonderful effects of CBD, but I’m not much of a straight up weed dog. But hey, I thought, I keep…
-
Sol Global (SOL.C): The only weed company I know that lists ‘divestments’ on its website
Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative journalists who write about nothing other than him, he’s got shareholders at various companies that have bought things from him screaming at him for taking their…
-
Marijuana update: Where the blood runs hard, look for the guys with swords
“There are times […] when even being right feels wrong. What do you say, for instance, about a generation that has been taught that rain is poison and sex is death? If making love might be fatal and if a cool spring breeze on any summer afternoon can turn a crystal blue lake into a…
-
Marijuana update: Speakeasy shuffle, Sproutly looming, Canopy CEO sell-off
Was just looking at a bunch of news releases, trying to figure out which to cover when I remembered, ‘didn’t you just use to do all of them?’ Why yes, self, I did. So let’s give ‘er to everyone, just like the old days. NOTHING EASY AT SPEAKEASY (EASY.C) I’ve had several nice discussions with…
-
Fundamental hype: As US MSO’s struggle, is National Access Cannabis (META.V) building the Canadian alternative?
About eighteen months ago, National Access Cannabis (META.V) emerged as part II of the Chuck Rifici master plan of Canadian weed v2.0 domination. His v1.0 domination plan was a company called Tweed, which later became Canopy Growth Corp (WEED.T). At a current $19.5 billion market cap, I guess you’d call that one a win, but…
-
iAnthus (IAN.C) retools stock option plan: Pitchforks and torches lowered as shorts bail
Sunlight is the best disinfectant, or so the old saying goes, meaning it’s only when bad things are exposed that bad things are corrected. US multi-state dispensary operator iAnthus (IAN.C), it seems, is soaking up the rays today. Hadley Ford, chief executive officer of iAnthus, stated: “We have cancelled recent option grants to members of…
-
![C21 Investments (CXXI.C): Now the clown car has emptied, C21 trades at 2.5x sales]()
C21 Investments (CXXI.C): Now the clown car has emptied, C21 trades at 2.5x sales
Back in December, I wrote a few stories about C21 Investments (CXXI.C), and how, at a $50 million market cap and $0.71 share price, and with $35m in revenues coming in from US assets, it was a bit of a steal. Someone, somewhere, agreed, and the share price of CXXI went on a tear from…
-
CLS Holdings (CLSH.U) reports another record-setting month with 85% revenue surge
CLS Holdings USA (CSE:CLSH.U) just topped $1 million in monthly sales. On Wednesday, the Las Vegas-based holding company behind Cannabis Life Sciences and Oasis reported a record-setting month of May with revenues surging across all major business streams. Record-breaking month In an official press release, CLS Holdings reported system-wide revenue of $1,058,867 U.S. in May,…
-
Wildflower Brands (SUN.C) fires stock out of a cannon to be first movers in BC dispensary scene
You’ve got to hand it to Wildflower Brands (SUN.C) boss William Maclean, he’s a sucker for an opportunity. Back in the day, Wildflower’s origin story was they were going to grow weed on Vancouver Island. But the residents went all NIMBY, so he looked to Washington State. Then he locked in on vapes, then CBDs,…
-
Cresco Labs’ (CL.C) no-premium acquisition offer of Origin House (OH.C) is… alright
This morning, Chicago-based Cresco Labs (CL.C) announced it would be acquiring Origin House (OH.C) (formerly CannaRoyalty) in an all-stock deal worth CAN$1.1 billion. The offer comes in at CAN$12.68 per Origin House share. Origin House closed Friday at $12.05, which leaves the premium on the deal being less than amazing. In fact, the stock has…
